Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.880
-0.120 (-3.00%)
At close: Jul 3, 2025, 1:00 PM
4.070
+0.190 (4.90%)
After-hours: Jul 3, 2025, 2:42 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $100.38 million as of July 3, 2025. Its market cap has decreased by -75.61% in one year.
Market Cap
100.38M
Enterprise Value
-84.33M
1-Year Change
-75.61%
Ranking
Category
Stock Price
3.88
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $100.38M, a decrease of -75.04%. That is a compound annual growth rate of -67.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 100.38M | -73.42% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |